Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
for Chronic Obstructive Pulmonary Disease (COPD)
Drug: Omalizumab
Sites in Houston +22 more locations
Sponsor: Johns Hopkins University
Sex: All·Age: 40+
Code: NCT07059091·Phase 2·Recruiting·Listed Jul 2025